Halozyme Therapeutics | Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q4 Dec/2025 -0.24 1.9 1.26 Feb/17 2026
FY2025Q3 Sep/2025 1.72 1.59 1.27 Nov/03 2025
FY2025Q2 Jun/2025 1.54 1.21 0.91 Aug/05 2025
FY2025Q1 Mar/2025 1.11 0.96 0.79 May/06 2025
FY2024Q4 Dec/2024 1.26 1.15 0.82 Feb/18 2025




Eps Cambiamento Data
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amarin USD 0.08 0.11 2025-09
Amgen USD 5.29 0.35 2025-12
Baxter International USD 0.44 0.25 2025-12
Cara Therapeutics USD -5.04 3.24 2024-12
Cytokinetics USD -1.5 1.05 2025-12
DBV Technologies USD -0.24 1.31 2025-09
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD -0.15 0.18 2024-09
Halozyme Therapeutics USD -0.24 1.96 2025-12
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
MannKind USD 0.01 0.06 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 0.66 0.21 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
United Therapeutics USD 7.7 0.54 2025-12
Vanda Pharmaceuticals USD -0.09 0 2024-12


Halozyme Therapeutics Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.